Dr. Liucheng Wu 吴留成
Chief Physician, Teaching Assistant
Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of gastric, colon, and rectal cancer. Adjuvant and neoadjuvant chemotherapy for gastrointestinal tumors.
Dr. Wu focuses on clinical care and basic research for gastrointestinal tumors. Expertise includes surgery for gastric and colorectal cancer and other gastrointestinal diseases. Research interests include predicting recurrence and metastasis in advanced gastrointestinal malignancies and treatment strategies. Participated in research projects funded by the Guangxi Natural Science Foundation and the National Natural Science Foundation.
Name order: in Chinese the family name comes first (Wu Liucheng). Papers usually list the name as Liucheng Wu or Wu L.
Selected publications
16 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Cancer, 2025 (senior author): Stacking classifiers based on integrated machine learning model: fusion of CT radiomics and clinical biomarkers to predict lymph node metastasis in locally advanced gastric cancer patients after neoadjuvant chemotherapy. PubMed 40329193
- BMJ Open, 2024 (first author): Fruquintinib plus oxaliplatin combined with S-1 (SOX) as neoadjuvant therapy for locally advanced gastric cancer (GC) or gastro-oesophageal junction adenocarcinoma (GEJ): a multicentre, phase II, single-arm, open-label clinical trial (FRUTINEOGA) protocol. PubMed 38341203
- J Surg Oncol, 2022 (first author): Nodal downstaging to ypN0 after neoadjuvant chemotherapy positively impacts on survival of cT4N+ GC/GEJ patients. PubMed 36001384
- Cancer Manag Res, 2019 (first author): Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: a propensity score matching analysis. PubMed 31308742
- Tumour Biol, 2016 (first author): A premature proposal for new liver cancer seromarkers. PubMed 26758434
- Tumour Biol, 2016 (first author): SATB2 suppresses gastric cancer cell proliferation and migration. PubMed 26508023
- Cochrane Database Syst Rev, 2011 (senior author): Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma. PubMed 22161435
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion